The TAR DNA-binding protein (TDP-43) (1) is a highly conserved and abundantly expressed protein among the mammals and invertebrates (2,3). The protein is mainly located in the nucleus as punctuated structures designated T-bodies (4), but it is also distributed in the cytoplasm as discrete RNA granules (5). Multiple cellular functions have been implicated to be regulated by TDP-43, which consist of, but are not restricted to, transcriptional repression, RNA processing including splicing, biogenesis of miRNAs, and even translation (reviewed in (6-8)). Some of these regulations have been shown to be mediated through the two RNA-recognition motifs (RRM1 and RRM2) and the C-terminal glycine-rich, prion-like GQN domain (6,7). Mutational studies have revealed that the RRM1 domain contributes much of the nucleic acid binding activity whereas the function of RRM2 is still unclear and appears to play a lesser role in RNA binding (7). Studies have also established that an intact GQN domain which recruits additional hnRNPs is also necessary for the splicing activity of TDP-43 (2,9).
The TAR DNA-binding protein (TDP-43) (1) is a highly conserved and abundantly expressed protein among the mammals and invertebrates (2, 3) . The protein is mainly located in the nucleus as punctuated structures designated T-bodies (4), but it is also distributed in the cytoplasm as discrete RNA granules (5) . Multiple cellular functions have been implicated to be regulated by TDP-43, which consist of, but are not restricted to, transcriptional repression, RNA processing including splicing, biogenesis of miRNAs, and even translation (reviewed in (6) (7) (8) ). Some of these regulations have been shown to be mediated through the two RNA-recognition motifs (RRM1 and RRM2) and the C-terminal glycine-rich, prion-like GQN domain (6, 7) . Mutational studies have revealed that the RRM1 domain contributes much of the nucleic acid binding activity whereas the function of RRM2 is still unclear and appears to play a lesser role in RNA binding (7) . Studies have also established that an intact GQN domain which recruits additional hnRNPs is also necessary for the splicing activity of TDP-43 (2, 9) .
More recently, TDP-43 has been identified as the major pathological signature protein of patients with the frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS) (10, 11) . In particular, the metabolism of TDP-43 in the diseased cells of FTLD-U and ALS are misregulated, resulting in the generation of polyubiquitinated, phosphorylated, and caspase 3-cleaved species concentrated in the ubiquitinated inclusions (UBIs) in the cytoplasm and, to a much less extent, in the nucleus. Often accompanied with formation of the cytoplasmic UBIs is depletion of the nuclear TDP-43 (10, 11) ; reviewed in (12) . A causative role of TDP-43 in the pathogenesis of these disease is genetically substantiated by the identification of more than 30 different mutations in its C-terminal GQN domain (reviewed in (13) ). The molecular basis of misregulation of the TDP-43 metabolism remains to be examined. Also unclear is the exact roles of TDP-43 in the pathogenesis of diseases with TDP-43 (+) UBIs. Both loss-of-function of TDP-43 and gain-of-cytotoxicity, e.g., as caused by the TDP-43 (+) UBIs, have been suggested to facilitate the disease initiation as well as propagation (reviewed in (6, 7, 12, 14) ).
Regarding the scenario of pathogenesis by loss-of-function of TDP-43, it is interesting to note that knockout of TDP-43 expression in mice and/ or Drosophila could result in defects of early embryonic developments, impairment of the motor function, and decrease of the learning ability (15) (16) (17) (18) (19) . These studies, among others, have evidenced the importance of TDP-43 in development and/or neuronal function, but they do not provide clues to the role of this protein in TDP-43 proteinopathies on the molecular level. With respect to the metabolism of TDP-43, it is interesting to note that the homeostatic concentration of TDP-43 in normal cells is tightly regulated in vivo, as evidenced by the similar cellular amounts of TDP-43 in between wild type ES cells and mutant ES with knock out of TDP-43 expression from one of the two alleles (15) . Similar observation was also made in analysis of transgenic (Tg) CamKII-TDP-43 mice, in which the TDP-43 amounts were similar between the heterozygous and homozygous Tg mice (20) . Significantly, TDP-43 has been shown recently to bind and enhance the degradation of its own mRNA (21) . This negative feedback loop provides one route through which the TDP-43 protein could auto-regulate its own cellular concentration.
In the following, we present evidence that function of the autophagy system, which is responsible for processing and degradation of the TDP-43 protein, is maintained in part through TDP-43 binding to and stabilization of the mRNA encoding one of the essential components of autophagy.
EXPERIMENTAL PROCEDURES
Plasmids-Plasmids encoding FLAG-TDP-43, and FLAG-TDP-43 (∆RRM1) have been described before (22) . Plasmids encoding a siRNA-resistant form of TDP-43, TDP-43 R , and its derivative lacking the RRM1 motif, TDP-43 R (∆RRM1), were constructed by site-directed mutagenesis of the third bases of 3 individual codons in the siRNA-1 target sequence of the corresponding wild type cDNAs.
Cell culture and Transfection-Neuro2A, a mouse neuroblastoma cell line, was cultured in minimum essential medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. NSC34, a motor neuronlike cell line (23) , and NIH3T3, a fibroblast cell line (24) , were maintained in Dulbecco's modified eagle medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. Transfections of the plasmid DNA and RNA oligos were performed in six-well dishes with lipofectamine 2000 (Invitrogen) as per user's manual.
The RNAi oligos targeting the TDP-43 mRNA (siRNA-1: sense, 5'-GGAUCUGAAAGACUAU UUC-3'; siRNA-2: sense, 5'-CCAAUGCUGAA CCUAAGCA-3' (25)) and ATG7 mRNA (ATG7-siRNA (26)), and the scRNA oligo with scrambled sequence were all purchased from Ambion (sequences are available on request). It should be noted here that approximately 50% of the Neuro2A cells transfected with the TDP-43 RNAi oligo, but not those transfected with the scRNA oligo, died at 72 hr post-transfection. This toxic effect of TDP-43 siRNA oligos on the viability of Neuro2A cells was also noted and reported by Iguchi et al. (25) .
For the rescue experiments, the different rescuing plasmids were transfected into Neuro2A cells after 24 hr of the RNAi oligo transfection. Samples were collected at 36 hr after the second transfection and analyzed.
To induce autophagy, serum starvation of the cells was done for 15 hr after RNAi oligo treatment for 48 hr.
RNA Immunoprecipitation (RNA-IP)-The RNA-IP were performed as described previously (22) .
Microarray Hybridization-Total RNAs were isolated using the TRIzol reagent (Invitrogen). The poly(A) + RNAs were used for labeling by biotin according to the standard GeneChip Expression Analysis Technical Manual (Affymetrix, Santa Clara, CA). Each of the six sets of labeled cRNA probes was hybridized to a Mouse genome 430 2.0 Array (Affymetrix). The data treatment and statistical analysis were carried out by using GeneSpring V 11.5 software (Agilent Technologies, Palo Alto, CA).
Antibodies-Antibodies used for immunoblotting and immunofluorescence staining included anti-FLAG (M2, Sigma), rabbit anti-TDP-43 (GeneTex), rabbit anti-ATG7 (Sigma), rabbit anti-LC3 (Sigma), guinea pig anti-p62 (Progen) and mouse anti-ubiquitin (Millipore).
Western Blot Analysis-Total proteins were resolved by SDS-PAGE, transferred onto PVDF membrane (Millipore, Billerica, MA), and hybridized with different antibodies in 5% non fat milk. For ubiquitin and p62 blot analysis, the total proteins were extracted in the urea buffer as described previously (19) before gel electrophoresis.
Actinomycin D (Act D) chasing-Neuro2A cells were transfected either with the scRNA oligo or siRNA-1 oligo for 48 hr. Actinomycin D (Sigma) was then added into the cell culture medium (5µg/ml), and cell samples were collected at 3 hour intervals. Total RNAs were isolated and analyzed by semi-quantitative RT-PCR. The PCR products were resolved on 1.5% agarose gels and the intensity of the DNA bands were quantitated using an Alpha Imager 2200 (Alpha Innotech Corporation). The trend lines were drawn using Microsoft Excel software. The p values were calculated by student's T-test.
Immunofluorescence staining-Neuro2A cells grown on cover slips were transfected with either the scRNA oligo or the siRNA-1 oligo for 48 hr. MG132 was added into the culture medium and incubated for overnight. Separately, untransfected Neuro2A cells were also treated with 10 µM MG132 (Sigma) or 10 mM 3-MA (Sigma) for overnight. For staining, the cells were first washed with phosphate buffered saline (PBS), fixed with 4% paraformaldehyde and subsequently permeablized with 0.1% Triton X-100. The cover slips were blocked with 10% donkey serum for one hour at room temperature and incubated with anti-TDP-43 (1:500; GeneTex) and anti-ubiquitin (1:500; Millipore) diluted in 1% donkey serum at 4 º C overnight. The cover slips were washed in PBS for three times and incubated with the secondary antibodies for 2 hours. The slips were mounted using Vecta Shield (Vector Laboratories) and the images were scanned in a Zeiss LSM 510 Meta confocal microscope. The confocal data were quantitated using the MetaMorph software (Molecular Devices).
Electron microscopy-For electron microscopy analysis, the cells were fixed by immersion in a mixture of 2.5% glutaraldehyde and 2.5% paraformaldehyde in 0.1M sodium cacodylate buffer. Post fixation was performed in 1% osmium tetraoxide followed by an overnight immersion in 1% uranylacetate dissolved in 50 mM maleate buffer. Standard procedures for dehydration and embedding in spur resin were employed and thin sections were examined in a TECNI Sprit TWIN, FEI electron microscope.
RESULTS

Loss-of-TDP-43 down-regulated ATG7-
To investigate the function of TDP-43 in neuronal cells, we first carried out RNAi knockdown experiments in Neuro2A cells, which is a mouse neuroblastoma cell line (27) . The Neuro2A cells were transfected either with scRNA oligo or with siRNA-1 oligo, and the total RNAs were isolated and subjected to microarray analysis using the Affymetrix mouse genome 430 2.0 array. The TDP-43 knockdown efficiency was more than 90% in three independent experiments that we carried out. The raw data of the microarray hybridization were analyzed with the GeneSpring (V11.5) software and a total of 221 differentially expressed genes were identified with a cut-off value of about 1.5-fold change (p value ≤ 0.05) in cells treated with the siRNA-1 oligo in comparison to cells treated with the scRNA oligo. Validation by semi-quantitative RT-PCR analysis of 10 randomly chosen genes indicated that the credibility of the microarray array data stood at 60%. Interestingly, among the genes the expression of which were affected upon TDP-43 knockdown was ATG7 (autophagy-related 7), a gene essential for autophagy and involved in the maintenance of cellular metabolism under physiological conditions (28) . However, the mRNA levels of other ATG genes, including ATG3, ATG5 and ATG12, did not change in our microarray hybridization analysis (J.K. Bose, data not shown).
As shown by semi-quantitative RT-PCR in To examine whether the decrease of the level of ATG7 mRNA upon TDP-43 knockdown was a general phenomenon, the siRNA-1 was transfected into another two cell lines, NSC34 and NIH3T3, and the ATG7 mRNA levels were analyzed by RT-PCR at 48 hr post-transfection. As shown in Fig. 1C , the ATG7 mRNA level was downregulated in both types of cells treated with siRNA-1 oligo (compare lanes 2 and 4 to lanes 1 and 3, respectively, Fig. 1C ).
To further analyze the lowering of the level of ATG7 by RNAi knockdown of TDP-43, we carried out rescue experiment in which the siRNA-1 oligo was co-transfected with plasmids overexpressing the siRNA-1-resistant forms of TDP-43, TDP-43 R and TDP-43 R (∆RRM1) which lacked the RNA-binding motif RRM1. As seen in Fig. 2 , exogenous expression of the full-length TDP-43 R (lanes 3, Fig. 2 ), but not TDP-43 R (∆RRM1) (lanes 4, Fig. 2 ), could rescue, albeit not complete, the siRNA-1-induced lowering of the level of either the level of ATG7 protein (lane 2, Fig. 2A ) or the ATG7 mRNA (lane 2, Fig. 2B ). This data further excluded the possibility of an offtarget effect by the siRNA-1 oligo. The reduction of the amounts of both the ATG7 mRNA and ATG7 protein upon knockdown of TDP-43 could be regulated at the level of transcription, RNA metabolism or protein processing. In view of the existence of the two RRMs in the TDP-43 polypeptide, we first examined whether TDP-43 could bind to the ATG7 mRNA. RNA-IP experiments were performed using total lysates prepared from Neuro2A cells transfected with pEF-FLAG, pEF-FLAG-TDP-43, and pEF-FLAG-TDP-43 (∆RRM1), respectively. The lysates were immunoprecipitated with anti-TDP-43 or anti-FLAG, and the RNAs contained within the immunoprecipitates were analyzed by RT-PCR. As shown in Supplemental Fig. 1A , use of anti-TDP-43 enriched ATG7 mRNA in the immunoprecipitate (compare lanes 2 and 3, top panel of Supplemental Fig. 1A) . In parallel, RNA-IP showed that FLAG-TDP-43 could interact with ATG7 mRNA but not FLAG-TDP-43 (∆RRM1) (compare lanes 3 and 4, top panel of Supplemental  Fig. 1B) . The data of Figs. 1 and 2 and Supplemental Fig. 1 indicated that TDP-43 interacted with the ATG7 mRNA and also maintained its steady state level. Furthermore, the RRM1 motif was required for this interaction and the rescue effect.
TDP-43 depletion promoted instability of ATG7 mRNA-Following the observation of binding of TDP-43 to the ATG7 mRNA, we first elucidated the time course of the decrease of the ATG7 mRNA level by knockdown of TDP-43. For this, total RNAs were isolated from Neuro2A cells transfected with scRNA oligo or siRNA-1 oligo at 12, 18, 24 and 48 hr post-transfection, and subjected to semi-quantitative RT-PCR analysis. As shown in Fig. 3A , the downregulation of ATG7 mRNA became visible at 18 hr and it was most evident at 48 hr post-transfection. We then compared the stability of the endogenous ATG7 mRNAs in cells treated with the scRNA oligo and the siRNA-1 oligo, respectively. For this, the cells were treated with the oligos for 48 hr and then incubated with 5µg/ml of actinomycin D (ActD). RNAs were isolated from the cells at different time intervals of the ActD incubation and analyzed by semi-quantitative RT-PCR. As shown in Figure  3B , TDP-43 depletion led to a decrease, by approximately 6 hr, of the half-life of the endogenous ATG7 mRNA. Thus, it appeared that under normal cellular conditions, the homeostatic concentration of ATG7 was maintained in part through stabilization of its mRNA as mediated by TDP-43.
TDP-43 knockdown inhibited autophagySince loss of ATG7 led to the impairment of autophagy (29, 30) , we tested whether the TDP-43-mediated downregulation of ATG7 also had a similar effect on autophagy. For this, we first probed the total lysates prepared from control and TDP-43 knockdown cells with antibody against LC3, or microtubule-associated protein light chain 3, the amounts of which reflected the relative autophagic activity in the cells (31) . As shown in the Western blot of Fig. 4A , RNAi knockdown of TDP-43 in cells cultured in complete medium led to a significant decrease of the amount of LC3-II (compare lanes 2 and 4 to 1 and 3, Fig. 4A) . A decrease of LC3-II upon TDP-43 knockdown was also observed when the serum-free medium was used to culture the cells and induce the autophagy (compare lanes 6 and 8 to lanes 5 and 7, Fig. 4A ). The changes in the patterns of LC3-I and LC3-II on the Western blots were in striking similarity to those occurred in cells with knockdown of ATG7 (Fig. 4B) , suggesting that TDP-43 positively regulated the autophagy as mediated through ATG7.
We further used electron microscopy to check whether the autophagy system was indeed affected by TDP-43 knockdown. Neuro2A cells transfected with the scRNA and siRNA-1 oligo, respectively, were cultured in serum-free medium for 15 hr, fixed, and examined under the electron microscope. As shown in the histogram of Fig. 4C , treatment of Neuro2A cells with siRNA-1 oligo resulted in a less number of the autophagosomes in their cytosol (exemplified in the bottom photos, Fig. 4C ) when compared with cells transfected with the scRNA oligo (exemplified in the top photos, Fig. 4C ).
Finally, we examined the status of ubiquitinated proteins in TDP-43 depleted Neuro2A cells. Ubiquitinated proteins were known to be degraded by both the autophagy and ubiquitin-proteasome system, or UPS (32-34). Furthermore, there were "cross-talks" between the autophagy and UPS (reviewed in (35) ), such as the inhibition of UPS by impairment of the autophagy (36, 37) . Longer inhibition of the autophagy even resulted in greater perturbation of UPS (36) . Consequently, ubiquitinated proteins would accumulate and form intracellular aggregates if either the autophagy or UPS was impaired with the use of drugs such as 3-MA (autophagy inhibitor) and MG132 (proteasome inhibitor) (36) . The formation of the intracellular aggregates was greatly enhanced upon inhibition of both the autophagy and UPS, e.g., with the combined use of ATG6 siRNA and MG132 in cell culture (38) . Notably, knockout of the ATG7 gene and the consequent impairment of the autophagy in mice also resulted in the accumulation of ubiquitinated protein aggregates in the cells (28, 30) .
Following the above, we carried out immuno fluorescence staining and Western blotting analyses of Neuro2A cells undergone different treatments inhibiting the autophagy and/or UPS. As exemplified in Supplemental Fig. 2 The function of TDP-43 in the stabilization of ATG7 mRNA becomes apparent from the ActD chase experiment of cells with or without RNAi knockdown of TDP-43 ( Figs. 1-3 ). With its two RRM domains, TDP-43 potentially should be able to bind to a variety of RNA species in vivo. Indeed, a number of TDP-43-binding mRNA substrates have been identified previously which include the mRNAs encoding the transmembrane conductance regulator (CFTR), apolipoprotein A2(APOA2), low molecular weight NF (NFL), Survival Motor Neuron (SMN), histone deacetylase 6 (HDAC6), and TDP-43 itself, respectively (21, 22, (39) (40) (41) (42) . Recently, more RNAs have been shown to bind to TDP-43 in vivo (43, 44) . In the case of TDP-43 interaction with the ATG7 mRNA, its RRM1 domain very likely plays a major role (Supplemental Fig. 1) . In interesting correlation, the RRM1 domain is also required for rescue of the ATG7 mRNA level by TDP-43 (Fig.  2) . It should be noted that TDP-43 has been shown before to also stabilize the hNFL mRNA by binding to the 3' UTR (41). Also, TDP-43 binds to the 3' UTR of its own mRNA and this binding facilitates the degradation of the TDP-43 mRNA by the exosome machinery (21) . This bilateral role of TDP-43 in regulating the stabilities of different RNAs is not without precedent. There are previous examples in which a protein, such as AUF1, could act both as a destabilizing factor of one mRNA and a stabilizing factor for another (45) . The exact mechanism through which TDP-43 protects the ATG7 mRNA from degradation remains to be elucidated.
Equally important, this study provides clear evidence for inhibition of the autophagy in TDP-43 depleted cells, as shown by the loss of the autophagy marker LC3-II protein (Fig. 4A) , the decrease of the number of autophagosomes (Fig.  4C) , the increase of the anti-ubiquitin immunoreactivity ( Fig. 5A and Supplemental Fig.  2) , and the elevation of the amounts of polyubiquitinated proteins as well as p62 (Fig. 5B) upon TDP-43 knockdown. Furthermore, inhibition of autophagy by knockdown of TDP-43 is remarkably similar to the effect of RNAi knockdown of ATG7 (Figs. 4A and 4B) . Autophagy is an important process in the cells for intracellular protein quality control (46, 47) . As already mentioned, inhibition of the autophagy compromises the ubiquitin-proteasome pathway (36, 37) . Evidence has been presented before that clearance of TDP-43 and its caspase-generated 35 kDa and 25 kDa fragments is processed through both the autophagy (48-50) as well as the proteasome pathway (48, 49) . For instance, use of the autophagy inhibitors like 3-MA (49) and autophagy activators like Rapamycin (50) increases and reduces, respectively, the accumulation of TDP-43. Also, TDP-43 interacts with ubiquilin, a polyubiquitin-binding protein that is involved in both autophagy and UPS (51, 52) . All these studies suggest the involvement of autophagy/UPS in the turnover of TDP-43 in normal cells. Thus, the scenario that TDP-43 participates in the maintenance of the function of autophagy provides an interesting example in which a substrate of autophagy, e.g., TDP-43, feeds back to positively regulate the autophagy.
Finally, the stabilization of the ATG7 mRNA and consequently the maintenance of a functional autophagy by TDP-43 support an important role of the loss-of-function of TDP-43 in the pathogenesis of neurodegenerative diseases signatured with TDP-43(+) UBIs (Fig. 6) . In particular, the removal of proteins with aberrant amounts and/or structures is essential for maintenance of the homeostasis of terminally differentiated cells such as the neurons (53). When the structure, cellular level, or sub-cellular location of TDP-43 is misregulated as the result of TDP-43 proteinopathiesassociated gene mutations, the functions of TDP-43 including the maintenance of the autophagy and consequently the UPS would be lost (Fig. 6 ). Abnormal accumulation of proteins including TDP-43 itself would then occur in cells with the defective autophagy and UPS, thus leading to the formation of TDP-43(+) UBIs and the induction of neuro-cytotoxicity, etc. It is interesting to note here that TDP-43(+) inclusions in the cerebellar sections of patients with TDP-43 proteinopathies are p62 immunoreactive (54). The relative contribution of the scenario depicted in Fig. 6 to TDP-43(+) proteinopathies awaits to be examined in the future.
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